Stay updated on Pembrolizumab in Lymphoma Subtypes Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Lymphoma Subtypes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Lymphoma Subtypes Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added recruitment status indicating the study is no longer enrolling. Also added new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updated header formatting with a new revision tag (Revision: v3.6.0).
    Difference
    0.4%
    Check dated 2026-06-13T00:23:16.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.5.4 to v3.5.5, indicating a newer version of the page. This change reflects versioning metadata rather than content changes.
    Difference
    0.0%
    Check dated 2026-06-05T22:52:58.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added to the page, replacing the previous Revision: v3.5.3. This reflects a new version of the page content without altering the study details.
    Difference
    0.0%
    Check dated 2026-05-15T14:28:06.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page’s footer “Revision” value was updated from v3.5.2 to v3.5.3, indicating a minor platform/version change without altering study details.
    Difference
    0.0%
    Check dated 2026-04-24T05:52:48.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Version bump from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:25:51.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    - Added inclusion criterion: B-cell lymphoma unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma.
    Difference
    0.0%
    Check dated 2026-04-02T14:59:47.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Lymphoma Subtypes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Lymphoma Subtypes Clinical Trial page.